The therapeutic effects of berberine plus sitagliptin in a rat model of fatty liver disease
Objective(s): Fatty liver disease (FLD) is a disorder related to accumulation of excess fat within the hepatocytes. In this study, the effects of Berberine, a natural compound, and Sitagliptin as a DPP-4 inhibitor, were observed in a rat model of FLD.Materials and Methods: Forty male rats were divid...
Main Authors: | Soraya Mehrdoost, Parichehreh Yaghmaei, Hanieh Jafary, Azadeh Ebrahim-Habibi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2021-04-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | https://ijbms.mums.ac.ir/article_17754_f7e7bc87a739546746ecc8f4603b49f4.pdf |
Similar Items
-
Overexpression of P16 reversed the MDR1-mediated DDP resistance in the cervical adenocarcinoma by activating the ERK1/2 signaling pathway
by: Yun Xiao, et al.
Published: (2019-07-01) -
Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway
by: Zhou Y, et al.
Published: (2019-03-01) -
Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease
by: Zhigang Wang, et al.
Published: (2010-11-01) -
Valsartan reduces NOX4 expression and halts diabetic nephropathy in streptozotocin induced diabetic rat model
by: Shymaa A. Maher, et al.
Published: (2019-08-01) -
Untersuchung einer monomeren Mutante der extrazellulär regulierten Kinase 2 (ERK2) bei kardialer Hypertrophie
by: Hümmert, Martin W.
Published: (2020)